FMR LLC - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
FMR LLC ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$554,360
-13.1%
57,566
-18.8%
0.00%
Q2 2023$637,785
-42.8%
70,865
-50.0%
0.00%
Q1 2023$1,114,468
-87.4%
141,790
-89.2%
0.00%
-100.0%
Q4 2022$8,862,374
-47.3%
1,311,002
+13.2%
0.00%
-50.0%
Q3 2022$16,808,000
+50.8%
1,158,385
+2.3%
0.00%
+100.0%
Q2 2022$11,143,000
-8.4%
1,132,442
+37.2%
0.00%0.0%
Q1 2022$12,166,000
+16.8%
825,350
+4.8%
0.00%0.0%
Q4 2021$10,415,000
-37.9%
787,220
-18.1%
0.00%0.0%
Q3 2021$16,769,000
-35.7%
960,961
-11.7%
0.00%
-50.0%
Q2 2021$26,087,000
-24.7%
1,088,790
-19.2%
0.00%
-33.3%
Q1 2021$34,630,000
+11.2%
1,347,970
-17.8%
0.00%0.0%
Q4 2020$31,149,000
+42.1%
1,640,278
-5.8%
0.00%
+50.0%
Q3 2020$21,926,000
+2.7%
1,741,613
-1.3%
0.00%0.0%
Q2 2020$21,342,000
+55.8%
1,763,856
-1.5%
0.00%0.0%
Q1 2020$13,700,000
-53.9%
1,790,791
+7.4%
0.00%
-33.3%
Q4 2019$29,689,000
+176.7%
1,666,978
+80.2%
0.00%
+200.0%
Q3 2019$10,729,000
-50.4%
924,945
-5.3%
0.00%
-66.7%
Q2 2019$21,629,000
+2.8%
976,480
+32.9%
0.00%0.0%
Q1 2019$21,036,000735,0140.00%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,719,576$25,679,00012.37%
Vivo Capital, LLC 1,618,296$30,731,0001.37%
Opaleye Management Inc. 470,203$8,929,0001.17%
INTERWEST VENTURE MANAGEMENT CO 388,766$7,383,0000.92%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 177,433$3,369,0000.92%
Ikarian Capital, LLC 1,063,961$20,204,0000.89%
Ghost Tree Capital, LLC 200,000$3,798,0000.85%
Logos Global Management LP 490,000$9,305,0000.80%
Eventide Asset Management 1,680,000$31,903,0000.49%
Affinity Asset Advisors, LLC 45,000$855,0000.45%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders